Change in shelf-life, storage conditions and manufacturing site for Tegretol 200 Tablet 200mg (SIN00352P)

Novartis would like to inform healthcare professionals of the change in the shelf life, storage conditions and manufacturing site for Tegretol 200 tablet 200mg. Due to these changes, healthcare professionals are advised not to mix the Tegretol tablets from the two different manufacturing sites when dispensing the medication. Healthcare professionals should inform patients of the changes and to advise them to complete the consumption of their old Tegretol tablets, manufactured by “Novartis Pharmaceuticals UK Ltd”, before starting on the new Tegretol tablets manufactured by “Novartis Farma SPA”. Please refer to the Dear Healthcare Professional Letter for more details.
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.moh.gov.sg/hpp/, and follow the procedures below to access the MOH Alert system.

Step 1: On the top navigation ribbon of webpage, select 'For Healthcare Professionals' followed by 'Health Professionals Portal' and click on the choice of profession. User will be redirected to the specific HPP webpage for the selected profession.

Step 2: Click on the Restricted Content icon on the left panel of webpage and login via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’ section

Step 4: Click on the Drug Alert tab to view the DHCPLs.